Hims & Hers Health, Inc.
Hims & Hers Reports Strong Q1 2025 Financial Results and Raises Guidance
Summary
Hims & Hers Health, Inc. reported a significant increase in revenue and subscribers for Q1 2025, achieving $586.0 million in revenue and 2.4 million subscribers. The company beat earnings expectations with a net income of $49.5 million and Adjusted EBITDA of $91.1 million. Management raised the full-year 2025 revenue guidance to $2.3 billion - $2.4 billion and Adjusted EBITDA guidance to $295 million - $335 million. The company also introduced long-term targets for 2030 with revenue of at least $6.5 billion and Adjusted EBITDA of at least $1.3 billion.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement